THE INTERNATIONAL CML FOUNDATION
The advancement of health by the improvement of the treatment in all parts of the world of chronic myeloid leukaemia and related diseases.
Objects
3.1. THE GENERAL CHARITABLE OBJECTS FOR WHICH THE FOUNDATION IS ESTABLISHED ARE THE ADVANCEMENT OF HEALTH BY THE IMPROVEMENT OF THE TREATMENT IN ALL PARTS OF THE WORLD OF CHRONIC MYELOID LEUKAEMIA AND RELATED DISEASES (TOGETHER "CML") AND FOR THE PURPOSE OF CARRYING OUT THOSE GENERAL OBJECTS THE PRIMARY OBJECTS OF THE FOUNDATION ARE IN PARTICULAR:- 3.1.1. TO IMPROVE CLINICAL PRACTICE AND DISEASE MONITORING IN THE TREATMENT OF CML3.1.2. TO SUPPORT ENCOURAGE AND PROMOTE RESEARCH INTO THE CAUSES, PREVENTION, STUDYAND TREATMENT OF CML3.1.3. TO PROMOTE AND SUPPORT THE EDUCATION OF AND DISSEMINATE KNOWLEDGE AMONGSTCLINICIANS, SCIENTISTS, HEALTH PROFESSIONALS AND PATIENTS IN MATTERS CONCERNINGCML3.1.4. TO PROMOTE, FOSTER AND CO-ORDINATE COLLABORATION THAT IS PARTICULARLY (BUT NOTEXCLUSIVELY) INTERNATIONAL AND IS NOT ONLY IN THE AREAS AND ACTIVITIES OF CLINICALPRACTICE DISEASE MONITORING AND RESEARCH INTO CML BUT ALSO IN ANY AREA ORACTIVITY WHICH IS OR MAY BE CONDUCIVE TO THE ACCELERATION OF THE CONTROL AND/ORCURE OF CML3.1.5. TO PROMOTE SET UP ESTABLISH AND SUPPORT AND SHARE AND EXCHANGE KNOWLEDGE WITH OTHER ORGANISATIONS WHOSE OBJECTS ARE SIMILAR TO THESE GENERAL OR PRIMARY OBJECTS3.1.6. TO ASSIST OR PROMOTE ANY OTHER CHARITABLE PURPOSES WHICH ARE RELATED TO THESEGENERAL AND PRIMARY OBJECTS
Financial health, per its FY2025 accounts
The accounts state that the charity's financial position remains solid, with total funds decreasing from £263,528 to £184,718 due to a net expenditure of £78,810. The trustees maintain a reserves policy to hold a minimum of £150,000, which is the amount required to operate for one year without further income. Unrestricted reserves of £4,318 are below this policy target, while restricted funds stand at £180,400.
What the accounts disclose
“The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was: 2025 1 £80,001 - £90,000” — page 12
“The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was: 2025 1” — page 12
“13% was allocated to fundraising” — page 4
“The Foundation plans to hold a minimum of £150,000 as reserve funding. This is the amount for the foundation to operate without further income/outgoings for one year.”
Policies the charity declares
- Bullying and harassment policy and procedures
- Campaigns and political activity policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
Trustees
- Dr TIMOTHY PETER HUGHESchair
- Dr ANDREAS HOCHHAUS
- Dr BRIAN DRUKER
- Dr Charles Schiffer
- Dr EDUARDO CORTES
- Dr JERALD RADICH
- Giuseppe Saglio
- Michael Mauro
- PROFESSOR JANE FELICITY APPERLEY
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/08/2025 | £267k | £346k |
| 31/08/2024 | £319k | £248k |
| 31/08/2023 | £107k | £244k |
| 31/08/2022 | £209k | £186k |
| 31/08/2021 | £69k | £147k |
Common questions
Is THE INTERNATIONAL CML FOUNDATION financially healthy?
Per its FY2025 accounts: The accounts state that the charity's financial position remains solid, with total funds decreasing from £263,528 to £184,718 due to a net expenditure of £78,810. The trustees maintain a reserves policy to hold a minimum of £150,000, which is the amount required to operate for one year without further income. Unrestricted reserves of £4,318 are below this policy target, while restricted funds stand at £180,400. Its FY2025 accounts were independently examined.
What does the highest-paid employee of THE INTERNATIONAL CML FOUNDATION earn?
Per its FY2025 accounts, the highest-paid employee was in the £80,001 - £90,000 band, and 1 employees earned over £60,000.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE MAURICE WOHL CHARITABLE FOUNDATION | 1 | £800k |
| THE CHARLES WOLFSON CHARITABLE TRUST | 1 | £425k |
| THE REGATTA FOUNDATION | 1 | £100k |
| THE PENNIES FOUNDATION | 1 | £95k |
| Blood Cancer UK Research | 1 | £87k |
| THE ERANDA ROTHSCHILD FOUNDATION | 1 | £70k |
| THE BENSON AND LIONEL BLACK CHARITABLE TRUST | 1 | £50k |
| THE UKI CHARITABLE FOUNDATION | 1 | £38k |
Charities like this
- CANCER CARE AND HAEMATOLOGY FUND
- THE CANCER TREATMENT AND RESEARCH TRUST CIO
- CURE LEUKAEMIA
- FOLLICULAR LYMPHOMA FOUNDATION
- THE BRITISH FRIENDS OF ZICHRON MENACHEM
- THE CHILDREN'S CANCER AND LEUKAEMIA GROUP
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE INTERNATIONAL CML FOUNDATION | £267k | £80,001 - £90,000 | 1 | unclear | 13.0% | no doubt |
| CANCER CARE AND HAEMATOLOGY FUND | £108k | — | 0 | unclear | — | no doubt |
| THE CANCER TREATMENT AND RESEARCH TRUST CIO | £502k | — | 0 | above | — | no doubt |
| CURE LEUKAEMIA | £3.7m | — | — | unclear | — | no doubt |
| FOLLICULAR LYMPHOMA FOUNDATION | £2.4m | £80,001 - £90,000 | — | unclear | — | no doubt |
| THE BRITISH FRIENDS OF ZICHRON MENACHEM | £152k | — | 0 | unclear | — | no doubt |